Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

COVID-19 can cause different skin issues, including rashes and hair loss.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

PRP is effective for treating hair loss, improving hair density, count, and thickness.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

COVID-19 can cause various skin issues, including rashes and lesions.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Infrared radiation can cause skin aging and cancer at high temperatures but may have therapeutic benefits at controlled levels.

Lasers are effective for some skin conditions but can cause side effects like scarring and pigment changes; careful selection is important, and botulinum toxin type A is successful in reducing sweat in palmar hyperhidrosis.

Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

ICG-enhanced NIR laser therapy may be a promising acne treatment with improvement and no side effects.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The article helps identify common, non-harmful skin conditions in newborns to avoid undue concern and treatment.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.